Read more

November 20, 2023
2 min watch
Save

VIDEO: Consider stem cell treatment for stubborn OSD cases

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Treatment with stem cells may be among the considerations in patients with ocular surface disease who have not responded to traditional therapy, according to a speaker at the Twin Cities Ocular Surface Disease Symposium.

“My lecture was on stem cells and how we should be looking at some of these more nuanced conditions, especially in those patients where we might be throwing the kitchen sink at them and we’re doing several treatments but they’re just not getting better,” Ahmad M. Fahmy, OD, FAAO, Dipl ABO, founder of the Twin Cities Ocular Surface Disease Symposium, co-founder of Eyes-On Dry Eye and practitioner at Minnesota Eye Consultants, said in this Healio video perspective.

“That’s what this whole meeting is about — trying to understand the condition at a very high level and help us identify some of these things that might fly under the radar, something that we might miss, especially in these tougher ocular surface disease patients.”